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Abstract Various studies in mice have found support for
the hypothesis that heterozygous carriers of cystic Wbrosis
transmembrane conductance regulator (CFTR) mutations
have an increased resistance to fatal infection compared to
both homozygous mutation carriers and non-carriers, while
in humans such evidence is scarce. In this study, we
assessed the CFTR heterozygotes survival advantage
hypothesis in a contemporary rural population that lives
under adverse environmental conditions in the Upper-East
region of Ghana. We genotyped 30 SNPs throughout the
CFTR gene in 4,230 participants and tested their inXuence
on survival and on body composition in the population at
large. With a sliding-window haplotype analysis, we identi-
Wed a set of six common haplotypes that inXuenced survival
probabilities (global p = 6.00 £ 10¡05). Individual haplo-
type analyses revealed two haplotypes of speciWc interest.
One of these haplotypes was enriched (p = 0.003), whereas
the other was depleted (p = 0.041) among people of old
age (¸65 years) compared to young study participants
(·5 years). In addition, children (n = 474) carrying the lat-
ter haplotype had lower body weight (ptrend = 0.020) and
height (ptrend = 0.010) compared to non-carriers. For all
these analyses, similar associations for heterozygous and
homozygous CFTR haplotype carriers were observed,
revealing an additive eVect of haplotype alleles. In conclu-
sion, we identiWed common haplotypes in the CFTR gene
that inXuence survival and body composition in the popula-
tion at large with no evidence for heterozygote advantage.
Introduction
The cystic Wbrosis transmembrane conductance regulator
(CFTR) gene contains a variety of mutations all of which
contribute to the development of cystic Wbrosis (CF). In
order to explain the high frequency of CF in various popu-
lations, it has been hypothesized that in our recent evolu-
tionary past heterozygous carriers of CFTR mutations have
had a survival advantage compared to both homozygous
mutation carriers and non-carriers (Danks et al. 1965). Pro-
posed mechanisms that would lead to such advantages are
an increased resistance to cholera, typhoid fever or tubercu-
losis (Gabriel et al. 1994; Hogenauer et al. 2000; Pier et al.
1996, 1998; Poolman and Galvani 2007; van de Vosse et al.
2005). Several studies with mouse models have provided
support for this hypothesis, where it has been shown that
heterozygous CFTR mutation carriers are more resistant to
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202 Hum Genet (2010) 127:201–206cholera-induced diarrhea, and against bacteria that use
CFTR for entering cells (Gabriel et al. 1994; Pier et al.
1998). In case of humans, however, support for this hypoth-
esis is generally lacking (Hogenauer et al. 2000; Jorde and
Lathrop 1988). Therefore, the aim of this study was to
assess the CFTR heterozygotes advantage hypothesis in a
contemporary rural population that lives under adverse
environmental conditions in the Garu-Tempane district, a
densely populated agricultural area in southeast of the
Upper-East region of Ghana (Meij et al. 2009; van Bodegom
et al. 2009). This region is highly endemic for malaria,
typhoid fever, diarrheal diseases and intestinal helminth
infections, whereas hospitals and medical services are only
marginally available. As there is evidence that the mutation
spectrum for CF in African populations is diVerent than in
European populations (Carles et al. 1996; Goldman et al.
2001; Padoa et al. 1999), we selected common variants
from the CFTR gene and tested its inXuence on survival as
well as on body composition in the population at large.
Materials and methods
Research area and study population
This study was conducted in the Garu-Tempane district, a
densely populated agricultural area in the southeast of the
Upper-East region of Ghana, which is inhabited by several
tribes, mostly Bimoba (67%) and Kusasi (27%) (Meij et al.
2009). The area is highly endemic for malaria, typhoid
fever, meningococcal disease and intestinal helminth infec-
tions. Hospitals and medical services are only marginally
available in the area. Vaccination of children was intro-
duced in the early 1990s, but coverage among children is
highly variable. It is estimated that about 50% of the chil-
dren under the age of 10 years have been vaccinated at least
once against measles, poliomyelitis or diphtheria–tetanus–
pertussis (Meij et al. 2009). The region and study popula-
tion have been described in more detail elsewhere (Meij
et al. 2009; van Bodegom et al. 2009). The Medical Ethical
Committee of the Ghana Health Service in Ghana, as well
as the Medical Ethical Committee of the Leiden University
Medical Center in the Netherlands approved the study.
Witness observed oral informed consent was obtained from
all participants.
The measurement of body composition and socioeconomic 
status (SES)
Weight (kg) and height (cm) were measured in 2007 for
474 children who were equal to or younger than 5 years of
age. In 2007 a DHS-type questionnaire was designed to
assess the SES of the study participants using a free listing
technique, whereby we asked people, both male and
female, from diVerent villages in the research area in focus
group discussions to list the household items of most value
(van Bodegom et al. 2009). The resulting list of valuable
items was comparable to part of the core welfare indica-
tions questionnaire (CWIQ) from the World Bank and to
the extended DHS asset list, adapted to our region.
SNP selection and genotyping
We selected 37 SNPs from the CFTR gene region covering
204.3 kbp (chr7:116897317-117101642) from the Hap-
Map database release #21 (http://www.hapmap.org) using
the Yoruba in Ibadan, Nigeria (Yoruba) data. The Haplo-
view’s program Tagger (Barrett et al. 2005) was used to
derive a set of tag SNPs from the whole gene region such
that each common SNP (¸5%) in that set was captured
with r2 ¸ 0.8. All SNPs were genotyped using mass spec-
trometry (Sequenom Inc, San Diego, CA, USA), according
to the manufacturer’s instructions. Altogether 4,336 partici-
pants were genotyped for 37 SNPs in the CFTR gene.
Genotyping failed for 7 SNPs as determined by more than
20% missing individuals. From the 4,336 participants 106
(2.44%) were excluded due to >50% missing genotypes,
leaving 4,230 participants for further analyses.
Statistical analysis
The program Haploview (Barrett et al. 2005) was used to
estimate allele frequencies, Hardy–Weinberg equilibrium
and pair-wise linkage disequilibrium (LD) between the
SNPs. Sliding-window haplotype analysis was performed
with the program Haplo.Stats (version 1.4.0) (Schaid et al.
2002). In this analysis, using a range of n.slide values, the
region with the strongest association will consistently have
low p-values for locus subsets containing the associated
haplotypes. The global p-value measures signiWcance of the
entire set of haplotypes for the locus subset. Haplo.stats
was also used to calculate and compare allele frequencies
between young and old study participants. Haplotypes and
haplotype frequencies per individual were calculated using
the program SNPHAP (http://wwwgene.cimr.cam.ac.uk/
clayton/software). The prevalence of CFTR haplotype alle-
les in elderly compared to young was analyzed using logis-
tic regression. For analyses with body weight and height,
these variables were Wrst converted into age-adjusted
z-scores ([individual level-mean level]/SD), in order to pro-
vide comparable estimates for haplotype eVects. The cross-
sectional associations between CFTR haplotypes and body
weight and height were performed using linear regression.
The linear and logistic regression analyses were performed
using STATA version 9 (StataCorp LP, TX, USA) statisti-
cal software. In all these analyses the posterior probabilities123
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HAP, were used as weights. All analyses were adjusted for
sex, SES and tribe. No evidence for population stratiWca-
tion or structure was detected when conducting non-para-
metric clustering of genotypes for 147 SNP genotyped in
controls (children ·5 years of age) and cases (elderly
¸65 years of age) using the AWClust algorithm (http://
awclust.sourceforge.net/).
Results
Altogether 30 single nucleotide polymorphisms (SNPs) in
the CFTR gene were genotyped in 4,230 participants (Sup-
plementary Table 1). From these participants 936 (22%)
were children of 5 years of age or younger (age range 0–5)
and 819 (19%) were 65 years of age or older (age range 65–
97) (Table 1). To assess whether genetic variants in the
CFTR gene inXuence survival in adverse environmental
conditions, we compared allele frequencies between these
young and old study participants. As linkage disequilibrium
(LD) within the CFTR gene is not strong, we used a sliding-
window haplotype analysis approach. With a window
length of four SNPs, strong associations for haplotype fre-
quency diVerences between young and old study partici-
pants were observed for two locations in the CFTR gene: in
the middle (global p = 6.00 £ 10¡05) and in the 3 end of
the gene (global p-value of 8.20 £ 10¡4) (Fig. 1). However,
only one very rare haplotype (population frequency 0.05%)
contributed to the association in the 3 end of the gene, and
therefore it was not investigated further.
In the middle of the CFTR gene, the rs213952,
rs10281281, rs17140174 and rs3808185 SNPs constitute
the window that associated with allele frequency diVer-
ences between young and old study participants. These
SNPs, give rise to six common haplotypes (frequency ¸
5%) (Fig. 2). From the individual haplotypes, haplotype 1
(frequency 26%) was depleted in participants of old age
(p = 0.041), whereas haplotype 5 (frequency 13%) was
enriched (p = 0.003) (Fig. 2). In addition, an additive eVect
of haplotype alleles for lower (ptrend = 0.06) and higher
(ptrend = 0.004) chances to reach an old age was observed
for carriers of haplotypes 1 and 5, respectively (Table 2).
Hence, no evidence for advantage or disadvantage for the
heterozygous haplotype carriers over homozygotes was
observed.
In addition to survival, we also assessed the inXuence of
CFTR haplotypes on weight and height in 474 children who
were equal to or younger than 5 years of age (mean age
3.42 years, SD 0.61). Carriers of haplotype 1 had lower
weight (ptrend = 0.020) and height (ptrend = 0.010), whereas
children carrying haplotype 5 had only marginal diVerences
in weight (ptrend = 0.11) and height (ptrend = 0.43) compared
to non-carriers (Fig. 3; Supplementary Table 2). Besides
these associations a beneWcial inXuence on body composi-
tion was observed for haplotype 4 (frequency 14%). Carri-
ers of this haplotype had higher weight (ptrend = 0.013) and
height (ptrend = 0.12) compared to non-carriers (Fig. 3; Sup-
plementary Table 2), even though they had similar survival
probabilities. For all these analyses similar associations
were observed for boys and girls, and for children from
compounds with diVerent socioeconomic status (data not
shown).
All these analyses were repeated using the four individ-
ual SNPs: rs213952, rs10281281, rs17140174 and
rs3808185. These analyses revealed associations with two
of these SNPs (rs10281281 and rs3808185), which, how-
ever, were not as strong as that in combination within a
haplotype (Supplementary Tables 3 and 4).
Table 1 Characteristics of the study population
n 4,230
Women (n, %) 2,888 (68%)
Elderly (¸65 years, n%) 819 (19%)
Children (·5 years, n%) 936 (22%)
Children ·5 years measured (n, %) 474 (11%)
Weight (mean, SD) 13.5 (1.84)
Height (mean, SD) 94.7 (7.04)
Fig. 1 The genetic structure of CFTR gene and ¡log p-values for the
global association of CFTR haplotype frequency diVerences between
young (·5 years, n = 936) and old (¸65 years, n = 819) study partici-
pants, as assessed by sliding-window haplotype analysis. Analysis was
adjusted for sex, socioeconomic status and tribe123
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frequencies in the general popu-
lation (n = 4,230) (a), and in the 
young (·5 years, n = 936) and 
old (¸65 years, n = 819) study 
participants (b). Underlining 
denotes the minor allele. DiVer-
ences in haplotype frequencies 
between young and old were 
analyzed using sex, socioeco-
nomic status and tribe adjusted 
Haplo.stats
Table 2 The prevalence of CFTR haplotypes in the group of old (¸65 years) study participants compared to young (·5 years)
Odds ratios were calculated using sex, socioeconomic status and tribe adjusted logistic regression
OR odds ratio, CI conWdence interval
* p < 0.05
Young versus old
0-copies
OR (95% CI)
1-copy
OR (95% CI)
2-copies
OR (95% CI)
ptrend
Haplotype 1 1 (reference) 0.91 (0.75–1.10) 0.69 (0.47–1.01) 0.06
Haplotype 2 1 (reference) 1.16 (0.96–1.41) 1.06 (0.66–1.71) 0.22
Haplotype 3 1 (reference) 1.15 (0.94–1.40) 0.85 (0.49–1.48) 0.47
Haplotype 4 1 (reference) 0.93 (0.76–1.14) 0.54 (0.27–1.08) 0.13
Haplotype 5 1 (reference) 1.26 (1.02–1.55)* 2.20 (1.07–4.52)* 0.004*
Haplotype 6 1 (reference) 1.07 (0.81–1.40) 1.14 (0.12–10.5) 0.65
Fig. 3 The inXuence of CFTR 
haplotypes on weight and height 
in children equal to or younger 
than 5 years of age (n = 474). 
Linear regression adjusted for 
sex, socioeconomic status and 
tribe123
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In this study we identiWed common CFTR haplotypes that
inXuence body composition in children and survival in the
population at large. In all our analyses we observed an
additive eVect of haplotype alleles and no selective advan-
tage for heterozygous carriers over both, homozygous
mutation carriers and non-carriers. This observation is in
accordance with the few other studies that have been con-
ducted (Hogenauer et al. 2000; van de Vosse et al. 2005).
Therefore, it has been hypothesized that other mechanisms,
such as a past selective event or random genetic drift,
would explain for the high frequency of CF in European
populations. Interestingly, the prevalence of CF and its
causal mutations are diVerent in populations of diVerent
origin, and do not coincide with locations in the world
where the proposed selective agents, such as cholera and
typhoid fever have the highest prevalence (Fontelo 1995).
In Africa the prevalence of CF is low and the mutation
spectrum for CF in African populations has been shown to
be diVerent than that in European populations (Carles et al.
1996; Goldman et al. 2001; Padoa et al. 1999). One reason
for the lower prevalence of CF in Africa could be that the
aVected individuals die in early childhood either due to the
lack of proper diagnosis and/or medical care. This might
also be the case in our research area.
On the other hand, the lack of evidence for selective
advantage for heterozygous carriers over both, homozygous
mutation carriers and non-carriers in our study could rely
on our selection of common variants in the CFTR gene,
instead of mutations that have been associated with CF. It
could be that the common variants contribute to mild func-
tional diVerences of the CFTR protein, leading to additive
eVects. In case of CFTR mutations, such eVects would be
observed for the heterozygous carriers, whereas homozy-
gous carriers would suVer CF.
Previously, it has been observed that children with
untreated or poorly controlled CF have poor growth, reX-
ected by lower weight and height (Miller et al. 1982; Mori-
son et al. 1997). Also in this study, genetic variants in the
CFTR gene inXuenced body composition. Carriers of hap-
lotype 1 had lower weight and height and this haplotype
was depleted in people of old age. This detrimental eVect
could be because of pancreatic insuYciency that leads to
malnutrition (Davies et al. 2007; Zielenski and Tsui 1995).
However, the mechanisms that lead to the enrichment of
haplotype 5 still need to be elucidated, since carriers of this
haplotype had no diVerences in body compositions com-
pared to non-carriers. The opposite was true for carriers of
haplotype 4, who had better body compositions but no sur-
vival advantage. It is known that variation in the CFTR
gene inXuences multiple phenotypes and it might be that
some variants are more detrimental to some phenotypes
than to others. In addition, the phenotypic inXuences of
CFTR variants can be aVected by other genes, as recently,
several modiWer genes for CF have been identiWed (Gu
et al. 2009; Levy et al. 2009).
The strengths of this study are the large population size
and the thorough evaluation of common variants in the
CFTR gene, which through linkage disequilibrium capture
the information for functional variants that were not geno-
typed. The limitations include the lack of data on body
composition for grown-ups, on the prevalence of diseases
and on the speciWc mortality causes. Therefore, we could
not directly assess the inXuence of CFTR variants on health.
In addition, considering the number of tests performed, it
cannot be excluded that some of the observed associations
were due to chance. Nevertheless, we identiWed common
haplotypes in the CFTR gene that inXuence survival and
body composition in the population at large.
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